The synthesis of twelve new palladium allyl complexes bearing benzimidazole-based NHC (NHC = N-heterocyclic carbene) ligands is reported. All the complexes were characterized by NMR and elemental analysis and, in the case of complex 5c, it was possible to confirm the connectivity by single crystal X-ray diffraction. The cationic palladium allyl complexes were tested toward 5 different cancer lines, with IC50 values generally lower than cisplatin and similar antiproliferative activity in the two ovarian cancer cell lines (A2780 and A2780cis), suggesting a different mechanism of action from classical platinum-based anticancer drugs. Compounds equipped with a pyridine arm or with the NHC/PTA combination (PTA = 1,3,5-triaza-7-phosphaadamantane) showed a lower cytotoxicity on normal cells with respect to cancer ones. By comparing the IC50 values of mixed NHC/PTA complexes reported in this work and their trifluoromethyl congeners recently published by our group, it appears evident that they have very similar antiproliferative activity against cancer cells but the absence of the CF3 group significantly decreases the selectivity toward them.

Synthesis, characterization and anticancer activity of palladium allyl complexes bearing benzimidazole-based N-heterocyclic carbene (NHC) ligands

Matteo Mauceri;Nicola Demitri;Vincenzo Canzonieri;
2021-01-01

Abstract

The synthesis of twelve new palladium allyl complexes bearing benzimidazole-based NHC (NHC = N-heterocyclic carbene) ligands is reported. All the complexes were characterized by NMR and elemental analysis and, in the case of complex 5c, it was possible to confirm the connectivity by single crystal X-ray diffraction. The cationic palladium allyl complexes were tested toward 5 different cancer lines, with IC50 values generally lower than cisplatin and similar antiproliferative activity in the two ovarian cancer cell lines (A2780 and A2780cis), suggesting a different mechanism of action from classical platinum-based anticancer drugs. Compounds equipped with a pyridine arm or with the NHC/PTA combination (PTA = 1,3,5-triaza-7-phosphaadamantane) showed a lower cytotoxicity on normal cells with respect to cancer ones. By comparing the IC50 values of mixed NHC/PTA complexes reported in this work and their trifluoromethyl congeners recently published by our group, it appears evident that they have very similar antiproliferative activity against cancer cells but the absence of the CF3 group significantly decreases the selectivity toward them.
2021
22-lug-2021
Pubblicato
https://www.sciencedirect.com/science/article/pii/S0277538721003636
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0277538721003636-main.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 1.1 MB
Formato Adobe PDF
1.1 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S0277538721003636-mmc1.pdf

Accesso chiuso

Descrizione: Supplementary data
Tipologia: Altro materiale allegato
Licenza: Copyright Editore
Dimensione 719.78 kB
Formato Adobe PDF
719.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
2994254_1-s2.0-S0277538721003636-main-Post_print.pdf

Open Access dal 24/07/2023

Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Creative commons
Dimensione 957.47 kB
Formato Adobe PDF
957.47 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2994254
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 7
social impact